Rapid point-of-care NT-proBNP testing on Radiometer's compact AQT90 flex immunoassay analyser could help to rule out heart faliure in up to 70% of patients,avoiding unnecessary testing and reducing costs.
Building on Radiometer’s proven track record for point-of-care testing, the AQT90 FLEX combines laboratory quality results with user-friendly instrumentation to provide rapid NT-proBNP results from whole blood in minutes.
Current NICE guidelines recommend serum natriuretic peptide or NT-proBNP testing for patients with suspected heart failure without previous MI, helping to avoid unnecessary echocardiograms and saving up to £100 per patient. The intuitive AQT90 FLEX provides precisely quantified NTproBNP results in just 10 minutes. Based on Radiometer’s innovative dry chemistry technology, the instrument’s closed tube system eliminates the need for sample preparation and batch testing, offering unrivalled operator safety and making it ideally suited to both pointof-care and laboratory environments.
Liz Grint, AQT90 Product Specialist at Radiometer, commented: “Whether you are looking for a cost-effective and high performance replacement for an existing service, or to establish NT-proBNP testing for the first time, the AQT90 FLEX can help you to improve your patient pathway.”
To find out more visit, www.radiometer.com/aqt90.